GREGORY D. PERRY - 25 Feb 2022 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Chief Financial Officer
Signature
/s/ Trey Reilly, Attorney-in-Fact
Issuer symbol
FNCH
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 17:50:33 UTC
Previous filing
21 Jun 2021
Next filing
02 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Employee Stock Option (right to buy) Award $0 +80,000 $0.000000 80,000 25 Feb 2022 Common Stock 80,000 $8.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.